On the recordDecember 10, 2013
I would suggest a tainted drug is very different from a drug labeling issue.
Source
congress.govEditor's note · Context
Collins distinguishes between issues of drug safety and labeling.
Share & report
More from Susan Collins
Mar 3, 2025
I do not think we should be pausing our efforts. It's the Ukrainians who are shedding blood.
Mar 5, 2025
The decision on whether to abolish the department is one that only Congress can make. The president does not have the authority to completely abolish the department.
Feb 12, 2025
the president had learned his lesson and would be much more cautious in the future
Feb 12, 2025
the cap on indirect costs under NIH grants was poorly conceived and would impose arbitrary cuts in funding for vital research at our Maine institutions.
Other voices in this conversation
